Guduchyadi yog in high cholesterol

Pharmaco-therapeutic effect of guduchyadi yog in the management of medo-roga w.s.r. to dyslipidemia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032077

Enrollment

Registered

2021-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: GUDUCHYADI YOG: 1gm TDS (3gm/day) with luke warm water for 60 days Control Intervention1: navak guggulu: 1gm TDS (3gm/day) with luke warm water for 60 days

Eligibility

Inclusion criteria

Inclusion criteria: BMI Serum cholesterol >201 mg/dl serum triglyceride >151 mg/dl serum low density lipoprotein >131 mg/dl

Exclusion criteria

Exclusion criteria: Unstable angina myocardial infraction, cardiac failure pregnancy/lactation peptic ulcer, ulcerative collitis impaired renal function

Design outcomes

Primary

Measure	Time frame
management of medoroga w.s.r. dyslipidemiaTimepoint: 60 days	—

Secondary

Measure	Time frame
to find the efficacy of guduchyadi yogTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Yogesh Singh

Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University,Jodhpur

drrajpurvia@gmail.com9782230577

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026